E-selectin and Inflammatory Bowel Disease
Author Information
Author(s): B. Vainer, O. H. Nielsen
Primary Institution: Department of Medical Gastroenterology C, Herlev Hospital, University of Copenhagen
Hypothesis
To assess serum levels of E-selectin and correlate it to disease activity in inflammatory bowel disease.
Conclusion
Serum E-selectin levels do not correlate with disease activity in inflammatory bowel disease, but E-selectin may play a role in recruiting immune cells during inflammation.
Supporting Evidence
- E-selectin levels were measured in IBD patients and healthy controls.
- No significant differences in serum E-selectin levels were found between IBD patients and healthy controls.
- A significant chemotactic response was observed at E-selectin concentrations of 1.00 nM and 3.14 nM.
Takeaway
The study looked at a protein called E-selectin in patients with bowel diseases and found that it doesn't help show how active the disease is, but it might help bring in immune cells to fight inflammation.
Methodology
Serum E-selectin levels were measured using a sandwich ELISA technique in 31 IBD patients and 15 healthy volunteers.
Limitations
The study did not include patients with other chronic inflammatory conditions, and the influence of anti-inflammatory drugs was not fully assessed.
Participant Demographics
31 patients with inflammatory bowel disease (16 with ulcerative colitis and 15 with Crohn's disease) and 15 healthy volunteers, aged 18-75.
Statistical Information
P-Value
p < 0.05 for chemotactic response at certain concentrations
Statistical Significance
p > 0.05
Want to read the original?
Access the complete publication on the publisher's website